{
  "BABA": "Alibaba Group Holding Limited (BABA) Unveils Qwen 2.5 AI Model, Claims Superiority Over DeepSeek-V3 and GPT-4oTop Analyst Reports for Alibaba, Airbnb & Royal Caribbean CruisesIs Alibaba Group Holding (BABA) the Best Blue Chip Stock to Buy Under $100?The Zacks Analyst Blog Highlights NVIDIA, Microsoft, Alphabet, Meta Platforms and AlibabaZacks Investment Ideas feature highlights: Microsoft, Meta Platforms, Alphabet, Nvidia and AlibabaE-Commerce Today - Rising MCOM Market Anticipates Substantial Growth by 2033Is Alibaba Group Holding Limited (BABA) the Best Asian Stock to Invest in According to Analysts? ",
  "DLB": "Dolby Laboratories Inc (DLB) Q1 2025 Earnings Call Highlights: Strong Revenue Growth and ...Compared to Estimates, Dolby Laboratories (DLB) Q1 Earnings: A Look at Key MetricsDolby's Q1 Earnings & Revenues Surpass Estimates, Increase Y/YQ1 2025 Dolby Laboratories Inc Earnings Call ",
  "NOK": "Nokia Stock Jumped on ThursdayNokia's Q4 Earnings Beat Estimates on Strong Revenue GrowthNokia Indicates its 5G Spending Drought Might be Near an EndNokia: Q4 Earnings SnapshotNokia beats estimates as demand recovers, shares rise ",
  "ICLK": "Latest News In Electric Vehicles - Battery Swapping Growth Fuels Global EV Sector ExpansionWhy GM stock has gotten hit hard on earnings ",
  "NIO": "Latest News In Electric Vehicles - Battery Swapping Growth Fuels Global EV Sector ExpansionWhy GM stock has gotten hit hard on earnings ",
  "PLTR": "Analysts Split on Palantir Technologies Inc. (PLTR): Jefferies Sees 65% Downside, While Wedbush Remains Bullish on AI GrowthPalantir Technologies Inc. (PLTR) Beats Stock Market Upswing: What Investors Need to KnowPalantir Gears Up for Q4 Earnings: What Lies Ahead for the Stock?Wall Street Analysts Think Palantir Technologies Stock Will Decline by 40% This Year. Are They Right?Can Palantir Technologies Stock Turn a $25,000 Investment Into More Than $1 Million?This Wall Street bank sees a 65% downside risk in Palantir stock ",
  "NVDA": "These 2 Medical Stocks Could Beat Earnings: Why They Should Be on Your RadarVertex Pharmaceuticals (NASDAQ:VRTX) lifts 3.2% this week, taking five-year gains to 83% "
}